3472.7000 36.30 (1.06%)
NSE Jul 31, 2026 15:04 PM
Volume: 176.8K
 

3472.70
1.06%
ICICI Direct
Q2FY26- Momentum driven by US and India Business - Revenues grew ~14% YoY to 1354 crore driven by US and India branded business which grew ~48% / ~12% to 344 crore and 432 crore, respectively. Other branded businesses such as Asia and Africa witnessed the growth of 5% / 4% (on higher base) to 310 crore and 221 crore, respectively. On the operational front, EBITDA grew 5.4% YoY to ~328 crore (excluding forex losses of 41 crore, 9 % growth to ~369 crore) with margins at 24.2%...
Ajanta Pharma Ltd. is trading above all available SMAs
More from Ajanta Pharma Ltd.
Recommended